showed a trendp = 0.065
Despite the small size of the ALL sub-cohort of relapsed patients with clinical data available (n = 13), the three patients with mutations showed a trend for shorter OS (HR, hazard ratio 6.4 95% CI 0.89–46.0.8, p = 0.065, Supplementary Fig.